Herewith three items of pandemic news you may have missed recently: Reinfection is more likely after age 65; the EU gives AstraZeneca’s vaccine a less than resounding go-ahead; and long Covid in children. Plus news briefs and a frippery. Long … Continue reading →
Herewith three items of pandemic news you may have missed recently: One instance in Oregon of a scary variant; quantifying the variants’ immune escape; and the new CDC guidelines. Plus news briefs and a frippery. A year Before we dive … Continue reading →
Herewith three items of pandemic news you may have missed recently: Youyang Gu’s model of the path to herd immunity; hesitancy from several directions about Johnson & Johnson’s vaccine; and the latest on pandemic passports. Plus news briefs and a … Continue reading →
Would the course of Covid-19 in this country have been different if Medicare had covered routine dental exams and cleanings? Possibly. But the studies have not been done that could tell us with confidence, and they probably won’t be. Determining … Continue reading →
Herewith three items of pandemic news you may have missed recently: A particular risk of diabetes with Covid-19; worries of vaccine escape by the South African variant; and the many ideas floated for bolstering vaccine supply. Plus a frippery. Ways … Continue reading →
I spent about 50 years doing software development, and one constant was that management always reported that projects were going to be finished in less than half the time than they were actually going to take, even if all went … Continue reading →
